Moderna (NASDAQ:MRNA) executives highlighted progress on cost reductions, a ramp in international partnerships, and multiple late-stage pipeline milestones during the company’s fourth-quarter 2025 ...

When HHS overhauled the CDC’s childhood immunization schedule in January, it significantly reduced the number of vaccines ...

Scientists say a cutting-edge gene-editing treatment could help people cut harmful high cholesterol levels in half — just after one treatment. A small trial of 15 people with high cholesterol, despite ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Cambridge drug and vaccine ...

Biotechnology company Moderna announced Monday that preliminary data suggests its half-dose booster shot increased antibody levels against Omicron compared with the levels seen when a fully vaccinated ...

TUESDAY, June 3, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory ...

Moderna's new option is a lower-dose version that is a step toward next-generation coronavirus vaccines. It’s called mNexspike. Moderna’s new COVID-19 vaccine is recommended as another option but not ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The new low-dose vaccine is one-fifth the size of ...

The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company’s existing shot, but a second option. The new vaccine, ...

The U.S. Food and Drug Administration has approved Moderna's next-generation Covid-19 vaccine for everyone aged 65 and above, the company said on Saturday, the first endorsement since the regulator ...